首页|某机构临床试验用药品管理的现存问题及改进措施

某机构临床试验用药品管理的现存问题及改进措施

扫码查看
目的 提升临床试验用药品管理水平,保证临床试验的质量。方法 调取 2021 年 3 月~2023 年 7 月某机构承接的 32 个在研项目的试验用药品管理的质控结果,对发现的问题进行归纳分析,并提出改进措施和建议。结果 汇总不合格项 25 项,共计 57 个问题。通过总结分析各环节出现的问题,从人员、管理、软硬件等方面找出试验用药品管理不规范的原因。提出了完善试验用药品的管理流程,增强试验用药品标准操作规程(SOP)和管理制度的可操作性,加强研究人员的培训,加强受试者的用药教育,建立试验用药品的信息化管理系统,对试验用药品进行定期质量管理的改进措施。结论 药物临床试验机构应加强试验用药品的管理和培训,通过建立《药物临床试验质量管理规范》(GCP)中心药房,配备专职药师,提高试验用药品管理水平,保证药物临床试验过程真实规范、结果科学可靠。
Problems and measures in the management of clinical trial drugs in an organization
Objective To improve the management level of clinical trial drugs and ensure the quality of clinical trials.Methods The results of quality control on the management of clinical trial drugs of 32 research projects undertaken by an organization from March 2021 to July 2023 were collected,and the problems were summarized and analyzed,and improvement measures and suggestions were put forward.Results The total number of unqualified items was 25,totaling 57 problems.By summarizing and analyzing the questions in each link,the reasons for irregularities in the management of clinical trial drugs were found in personnel,management,software and hardware.Improvement measures were proposed to improve the management process of clinical trial drugs,enhance the operability of the SOP and management system of clinical trial drugs,strengthen the training of research personnel,strengthen the medication education of subjects,establish the information management system of clinical trial drugs,and carry out regular quality management of clinical trial drugs.Conclusion Clinical drug trial institutions should strengthen the management and training of trial drugs,establish a GCP central pharmacy,equip full-time pharmacists,improve the management level of trial drugs,and ensure that the drug clinical trial process is authentic and standardized,and the results are scientific and reliable.

Experimental drugsDrug clinical trialManagementProblemsMeasures

黎静波、彭评志

展开 >

玉林市第一人民医院药物临床试验机构办公室,广西玉林 537000

试验用药品 药物临床试验 管理 问题 措施

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(5)
  • 19